Abiomed products

The Impella RP heart pump provides temporary, circulatory support for patients who develop right heart failure. It is the only FDA-approved heart pump indicated for patients experiencing acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infraction, heart transplant or open-heart surgery.

The Impella CP with SmartAssist heart pump is designated as safe and effective by the FDA for use during high-risk PCI procedures and for patients in cardiogenic shock. It is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery.

The Impella 5.5 with SmartAssist heart pump delivers full cardiac support, allowing the heart to rest and enabling the heart to achieve its natural pumping function without additional support. This heart pump is designed for long-duration support, enables patient mobility and optimizes recovery by using real-time intelligence.

Impella 5.0 is a temporary, minimally invasive heart pump that provides circulatory support, enabling the heart to rest and recover. Impella LD is a surgically implanted heart pump that provides temporary support to the heart during and after a procedure. Impella 5.0 and Impella LD heart pumps allow patients to walk around while on support to improve recovery, if inserted via the axillary artery near the shoulder. These heart pumps allow for the opportunity to provide longer duration of support for critically ill patients and a longer period to assess heart recovery.

The Impella 2.5 heart pump temporarily maintains blood flow during high-risk PCI procedures or cardiogenic shock. It allows the heart to rest and pumps blood to vital organs while the physician treats the underlining disease.